227 related articles for article (PubMed ID: 17278820)
1. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.
Dolan J; Lia Z; Williamson JF
Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820
[TBL] [Abstract][Full Text] [Related]
2. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
[TBL] [Abstract][Full Text] [Related]
4. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed.
Patel NS; Chiu-Tsao ST; Williamson JF; Fan P; Duckworth T; Shasha D; Harrison LB
Med Phys; 2001 Aug; 28(8):1761-9. PubMed ID: 11548947
[TBL] [Abstract][Full Text] [Related]
5. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
Kennedy RM; Davis SD; Micka JA; DeWerd LA
Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
[TBL] [Abstract][Full Text] [Related]
6. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
Rodriguez M; Rogers DW
Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
[TBL] [Abstract][Full Text] [Related]
7. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
Chiu-Tsao ST; Medich D; Munro J
Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
[TBL] [Abstract][Full Text] [Related]
8. Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed.
Anagnostopoulos G; Baltas D; Karaiskos P; Sandilos P; Papagiannis P; Sakelliou L
Med Phys; 2002 May; 29(5):709-16. PubMed ID: 12033566
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
[TBL] [Abstract][Full Text] [Related]
10. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
Meigooni AS; Hayes JL; Zhang H; Sowards K
Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
[TBL] [Abstract][Full Text] [Related]
12. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo calculations of dosimetry parameters of the urocor prostaseed 125I source.
Li Z
Med Phys; 2002 Jun; 29(6):1029-34. PubMed ID: 12094972
[TBL] [Abstract][Full Text] [Related]
14. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays.
Abboud F; Hollows M; Scalliet P; Vynckier S
Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric characterization of a 131Cs brachytherapy source by thermoluminescence dosimetry in liquid water.
Tailor R; Ibbott G; Lampe S; Warren WB; Tolani N
Med Phys; 2008 Dec; 35(12):5861-8. PubMed ID: 19175142
[TBL] [Abstract][Full Text] [Related]
16. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed.
Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I
Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848
[TBL] [Abstract][Full Text] [Related]
17. Using LiF:Mg,Cu,P TLDs to estimate the absorbed dose to water in liquid water around an 192Ir brachytherapy source.
Lucas PA; Aubineau-Lanièce I; Lourenço V; Vermesse D; Cutarella D
Med Phys; 2014 Jan; 41(1):011711. PubMed ID: 24387503
[TBL] [Abstract][Full Text] [Related]
18. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
19. Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV).
Tedgren AC; Hedman A; Grindborg JE; Carlsson GA
Med Phys; 2011 Oct; 38(10):5539-50. PubMed ID: 21992372
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry of the I-Plant Model 3500 iodine-125 brachytherapy source.
Duggan DM; Johnson BL
Med Phys; 2001 Apr; 28(4):661-70. PubMed ID: 11339764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
